Exposure to Air Pollutants and Lewy Body and Parkinson Disease–Related Dementias - Takeaways - MDSpire

Exposure to Air Pollutants and Lewy Body and Parkinson Disease–Related Dementias

  • By

  • Dimitry S. Davydow

  • Gregory M. Pontone

  • Michael S. Okun

  • Melissa J. Armstrong

  • Theresa Wimberley Böttger

  • Camila Geels

  • Lise Marie Frohn

  • Jørgen Brandt

  • Julie Werenberg Dreier

  • Jakob Christensen

  • Carsten Bøcker Pedersen

  • Henriette Thisted Horsdal

  • May 14, 2026

  • 0 min

Share

  • 1

    Parkinson disease (PD) is the fastest increasing neurodegenerative disease globally, with rising incidence and prevalence of PD-related dementia (PDD).

  • 2

    Air pollutants, particularly PM2.5, cross the blood-brain barrier and are linked to increased risks of neurodegenerative diseases, including DLB and PDD.

  • 3

    Long-term exposure to PM2.5 is associated with a 12% increased risk of hospitalization in DLB patients and a 17% increased risk in PDD patients.

  • 4

    The study utilized Danish nationwide registries to assess the relationship between air pollution exposure and the risk of DLB and PDD.

  • 5

    The research adjusted for sociodemographic factors and medical comorbidities to ensure accurate assessment of the impact of air pollution on dementia risk.

Original Source(s)

Exposure to Air Pollutants and Lewy Body and Parkinson Disease–Related Dementias

  • by Dimitry S. Davydow, Gregory M. Pontone, Michael S. Okun, Melissa J. Armstrong, Theresa Wimberley Böttger, Camila Geels, Lise Marie Frohn, Jørgen Brandt, Julie Werenberg Dreier, Jakob Christensen, Carsten Bøcker Pedersen, Henriette Thisted Horsdal

  • May 14, 2026

Related Content

Acupuncture effects on non-motor symptoms of Parkinson’s disease (sleep, mood, and fatigue): a systematic review and meta-analysis

Comprehensive Review of Advances and Translational Obstacles in Intelligent Multimodal Monitoring for Parkinson's Disease

The novel GLP-1/GIP dual receptor agonist DA5-CH is superior to tirzepatide and exendin-4 in the 6-OHDA Parkinson rat model